The global Aarskog Scott syndrome treatment market is expected to grow significantly from a projected US$3.20 billion in 2023 to US$6 billion by 2033. This indicates a strong 6.5% compound annual growth rate (CAGR) for the 2023–2033 projected period. The historical CAGR of 3% between 2018 and 2022 is surpassed by this growth. A rare genetic condition …